相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study
Jean-Michel Molina et al.
LANCET INFECTIOUS DISEASES (2012)
Thymic tissue is not evident on high-resolution computed tomography and [18F]Fluoro-deoxyglucose positron emission tomography scans of aviraemic HIV patients with poor recovery of CD4+ T cells
Sara Tanaskovic et al.
AIDS (2011)
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy
Ronald J. Ellis et al.
AIDS (2011)
Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients
Victor Appay et al.
AIDS (2011)
Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults
Harold W. Jaffe et al.
AIDS (2011)
Peritransplant palifermin use and lymphocyte recovery after T-cell replete, matched related allogeneic hematopoietic cell transplantation
Romee Rizwan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Long-term restoration of the human T-cell compartment after thymectomy during infancy: a role for thymic regeneration?
Rogier van Gent et al.
BLOOD (2011)
IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques
Enrico Lugli et al.
BLOOD (2011)
HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis
Delphine Sauce et al.
BLOOD (2011)
High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort
Damalie Nakanjako et al.
BMC INFECTIOUS DISEASES (2011)
The role of naive T-cells in HIV-1 pathogenesis: An emerging key player
Gabriela Khoury et al.
CLINICAL IMMUNOLOGY (2011)
Reduced Thymic Output Is a Major Mechanism of Immune Reconstitution Failure in HIV-Infected Patients After Long-term Antiretroviral Therapy
Taisheng Li et al.
CLINICAL INFECTIOUS DISEASES (2011)
Anal Cancer: Focus on HIV-Positive Patients in the HAART Era
Ernesto Zanet et al.
CURRENT HIV RESEARCH (2011)
Tesamorelin A Review of its Use in the Management of HIV-Associated Lipodystrophy
Sohita Dhillon
DRUGS (2011)
Late HIV presentation: epidemiology, clinical implications and management
Laura Waters et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials
T. Sivakumar et al.
HIV MEDICINE (2011)
Low Level of Regulatory T Cells and Maintenance of Balance Between Regulatory T Cells and TH17 Cells in HIV-1-Infected Elite Controllers
Lea Brandt et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response
Hiroyu Hatano et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Intensification of Antiretroviral Therapy With Raltegravir or Addition of Hyperimmune Bovine Colostrum in HIV-Infected Patients With Suboptimal CD4+ T-Cell Response: A Randomized Controlled Trial
Helen Byakwaga et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Valganciclovir Reduces T Cell Activation in HIV-infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy
Peter W. Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
An Exploratory Trial of Cyclooxygenase Type 2 Inhibitor in HIV-1 Infection: Downregulated Immune Activation and Improved T Cell-Dependent Vaccine Responses
Frank O. Pettersen et al.
JOURNAL OF VIROLOGY (2011)
Keratinocyte growth factor enhanced immune reconstitution in murine allogeneic umbilical cord blood cell transplant
Yi Wang et al.
LEUKEMIA & LYMPHOMA (2011)
Evidence for Polymicrobic Flora Translocating in Peripheral Blood of HIV-Infected Patients with Poor Immune Response to Antiretroviral Therapy
Esther Merlini et al.
PLOS ONE (2011)
Impact of Non-HIV and HIV Risk Factors on Survival in HIV-Infected Patients on HAART: A Population-Based Nationwide Cohort Study
Niels Obel et al.
PLOS ONE (2011)
Eradication of HIV by Transplantation of CCR5-Deficient Hematopoietic Stem Cells
Gero Huetter et al.
THESCIENTIFICWORLDJOURNAL (2011)
Th17 cells and regulatory T cells in elite control over HIV and SIV
Dennis J. Hartigan-O'Connor et al.
CURRENT OPINION IN HIV AND AIDS (2011)
Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV
Tomas Mellberg et al.
AIDS RESEARCH AND THERAPY (2011)
Harnessing the biology of IL-7 for therapeutic application
Crystal L. Mackall et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Effect of 25 weeks probiotic supplementation on immune function of HIV patients
Ruben Hummelen et al.
GUT MICROBES (2011)
Skewed T-cell maturation and function in HIV-infected patients failing CD4+ recovery upon long-term virologically suppressive HAART
Giulia Marchetti et al.
AIDS (2010)
HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses
Rachel E. Owen et al.
AIDS (2010)
Risk and vulnerability: do socioeconomic factors influence the risk of acquiring HIV in Asia?
Robert Greener et al.
AIDS (2010)
Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy
Stefania Piconi et al.
AIDS (2010)
CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART
Marta Massanella et al.
AIDS (2010)
Treatment with Recombinant Growth Hormone Is Associated with Modest Improvement in CD4 Lymphocyte Reconstitution in HIV-Infected Persons on Antiretroviral Therapy: Results of ACTG A5174
Kimberly Smith et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2010)
Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: A cohort study
Frederik N. Engsig et al.
BMC INFECTIOUS DISEASES (2010)
Relationship Between Current Level of Immunodeficiency and Non-Acquired Immunodeficiency Syndrome-Defining Malignancies
Joanne Reekie et al.
CANCER (2010)
Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment-Experienced Patients with Drug-Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials
Roy T. Steigbigel et al.
CLINICAL INFECTIOUS DISEASES (2010)
Involvement of Regulatory T Cells in HIV Immunopathogenesis
Sara S. Bernardes et al.
CURRENT HIV RESEARCH (2010)
Role of Interleukin-2 in Patients with HIV Infection
Sarah L. Pett et al.
DRUGS (2010)
The Relationship of CCR5 Antagonists to CD4+T-Cell Gain: A Meta-Regression of Recent Clinical Trials in Treatment-Experienced HIV-Infected Patients
Timothy J. Wilkin et al.
HIV CLINICAL TRIALS (2010)
T-Cell Dysfunction in HIV-1-Infected Patients With Impaired Recovery of CD4 Cells Despite Suppression of Viral Replication
Christian Erikstrup et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Structural Interventions for HIV Prevention in the United States
Adaora A. Adimora et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Identification of PD-1 as a Unique Marker for Failing Immune Reconstitution in HIV-1–Infected Patients on Treatment
Katharina Grabmeier-Pfistershammer et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Increased CD4+ T Cell Levels during IL-7 Administration of Antiretroviral Therapy-Treated Simian Immunodeficiency Virus-Positive Macaques Are Not Dependent on Strong Proliferative Responses
Amanda Leone et al.
JOURNAL OF IMMUNOLOGY (2010)
Sustained Low-Dose Growth Hormone Therapy Optimizes Bioactive Insulin-Like Growth Factor-I Level and May Enhance CD4 T-Cell Number in HIV Infection
Ove Andersen et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs
Christoph C. Carter et al.
NATURE MEDICINE (2010)
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study
R. K. Heaton et al.
NEUROLOGY (2010)
Increased Bone Marrow Interleukin-7 (IL-7)/IL-7R Levels but Reduced IL-7 Responsiveness in HIV-Positive Patients Lacking CD4+Gain on Antiviral Therapy
Giusi Maria Bellistri et al.
PLOS ONE (2010)
Qualitative Immune Modulation by Interleukin-2 (IL-2) Adjuvant Therapy in Immunological Non Responder HIV-Infected Patients
Francesca Sabbatini et al.
PLOS ONE (2010)
Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease
David Favre et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Th17, gut, and HIV: therapeutic implications
Peter W. Hunt
CURRENT OPINION IN HIV AND AIDS (2010)
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study The Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group
S. W. Worm et al.
AIDS (2010)
Improved thymic index, density and output in HIV-infected patients following low-dose growth hormone therapy: a placebo controlled study
Birgitte R. Hansen et al.
AIDS (2009)
Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study
Julia Bohlius et al.
ANTIVIRAL THERAPY (2009)
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection
Irini Sereti et al.
BLOOD (2009)
Increased levels of regulatory T cells (T-regs) in human immunodeficiency virus-infected patients after 5 years of highly active anti-retroviral therapy may be due to increased thymic production of naive T-regs
L. Kolte et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
IL-2, IL-7 and IL-15 as Immuno-Modulators During SIV/HIV Vaccination and Treatment
Amanda Leone et al.
CURRENT HIV RESEARCH (2009)
Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment
Yves Levy et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral-Treated HIV Infection
Wei Jiang et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
High Levels of Chronic Immune Activation in the T-Cell Compartments of Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus Type 1 and on Highly Active Antiretroviral Therapy Are Reverted by Alpha Interferon and Ribavirin Treatment
Veronica D. Gonzalez et al.
JOURNAL OF VIROLOGY (2009)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont et al.
NATURE MEDICINE (2009)
HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy
Maud Mavigner et al.
PLOS ONE (2009)
HIV-infected Patients with a Large Thymus Maintain Higher CD4 Counts in a 5-year Follow-up Study of Patients Treated with Highly Active Antiretroviral Therapy
L. Kolte et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
HIV, alcohol, and noninjection drug use
Hong Van Tieu et al.
CURRENT OPINION IN HIV AND AIDS (2009)
The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms
Jason V. Baker et al.
CURRENT OPINION IN HIV AND AIDS (2009)
Critical Loss of the Balance between Th17 and T Regulatory Cell Populations in Pathogenic SIV Infection
David Favre et al.
PLOS PATHOGENS (2009)
Reduction of the HIV-1 reservoir in resting CD4+ T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study
Annica Lindkvist et al.
AIDS Research and Therapy (2009)
CIGARETTE SMOKING AND HIV: MORE EVIDENCE FOR ACTION
Nancy R. Reynolds
AIDS EDUCATION AND PREVENTION (2009)
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies
A. d'Arminio Monforte et al.
AIDS (2008)
The role of HIV in serious diseases other than AIDS
Andrew N. Phillips et al.
AIDS (2008)
Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy
Giulia Marchetti et al.
AIDS (2008)
Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men
Robert C. Kaplan et al.
AIDS (2008)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Recombinant human growth hormone - Rationale for use in the treatment of HIV-associated lipodystrophy
Stefano Benedini et al.
BIODRUGS (2008)
Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy
J. C. Gaardbo et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART
Antonella Isgro et al.
CLINICAL INFECTIOUS DISEASES (2008)
Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy
Felix Gutierrez et al.
CURRENT HIV RESEARCH (2008)
Disruption of the γc cytokine network in T cells during HIV infection
Danylo Sirskyj et al.
CYTOKINE (2008)
Changes in the risk of death after HIV seroconversion compared with mortality in the general population
Krishnan Bhaskaran et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Growth hormone enhances thymic function in HIV-1-infected adults
Laura A. Napolitano et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
Claude Sportes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals
Susan Moir et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Restoration of the CD4 T cell compartment after long-term highly active Antiretroviral therapy without phenotypical signs of accelerated immunological aging
Nienke Vrisekoop et al.
JOURNAL OF IMMUNOLOGY (2008)
Relationship between T cell activation and CD4(+) T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy
Peter W. Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Inferior clinical outcome of the CD4+ cell count guided antiretroviral treatment interruption strategy in the SMART study:: Role of CD4+ cell counts and HIV RNA levels during follow-up
Jens D. Lundgren et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy
Tae-Wook Chun et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
LANCET (2008)
Maraviroc for previously treated patients with R5 HIV-1 infection
Roy M. Gulick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
HIV-1 Infection of Bone Marrow Hematopoietic Progenitor Cells and Their Role in Trafficking and Viral Dissemination
Aikaterini Alexaki et al.
PLOS PATHOGENS (2008)
IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-Specific CD8(+) T cell responses
Yvonne M. Mueller et al.
JOURNAL OF IMMUNOLOGY (2008)
Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections
Dimitrios Vassilopoulos et al.
CURRENT OPINION IN RHEUMATOLOGY (2007)
Intravenous immunoglobulin (IVIG) treatment for modulation of immune activation in human immunodeficiency virus type 1 infected therapy-naive individuals
Joost N. Vermeulen et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic children
Sonja Junge et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Role of recombinant human growth hormone in HIV-Associated wasting and cachexia: Pathophysiology and rationale for treatment
Marie Gelato et al.
CLINICAL THERAPEUTICS (2007)
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study
A. Mocroft et al.
LANCET (2007)
Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy
Andrew Lim et al.
AIDS (2007)
Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques
Ruth Seggewiss et al.
BLOOD (2007)
Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4+ T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1)
Ornella Franzese et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Class of antiretroviral drugs and the risk of myocardial infarction
Nina Friis-Moller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging
Dullei Min et al.
BLOOD (2007)
CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression
Richard D. Moore et al.
CLINICAL INFECTIOUS DISEASES (2007)
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley et al.
NATURE MEDICINE (2006)
Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)
Bruce R. Blazar et al.
BLOOD (2006)
Mucosal but not peripheral FOYP3+ regulatory T cells are highly increased in untreated HIV infection and nonnalize after suppressive HAART
Hans-Joerg Epple et al.
BLOOD (2006)
An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults
John A. Bartlett et al.
AIDS (2006)
T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART
Marco Marziali et al.
AIDS (2006)
Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy
Pierre Delobel et al.
JOURNAL OF VIROLOGY (2006)
Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART
Giulia Marchetti et al.
AIDS (2006)
Antiretroviral treatment of HIV infected adults
Steven G. Deeks
BMJ-BRITISH MEDICAL JOURNAL (2006)
IL-15 induces C4+ effector memory T cell production and tissue emigration in nonhuman primates
Louis J. Picker et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Thymic volume predicts CD4 T-cell decline in HIV-infected adults under prolonged treatment interruption
Sonia Molina-Pinelo et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
Using age, cohort, and period to study elderly volunteerism
E Rosenberg et al.
EDUCATIONAL GERONTOLOGY (2006)
Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment
D Kvale et al.
AIDS (2006)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART)
Christoph Steininger et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation
JM Benito et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Loss of IL-7Rα is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients
B Rethi et al.
AIDS (2005)
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/μL in HIV type 1-infected individuals receiving potent antiretroviral therapy
GR Kaufmann et al.
CLINICAL INFECTIOUS DISEASES (2005)
IL-15 and HIV infection: Lessons for immunotherapy and vaccination
A Ahmad et al.
CURRENT HIV RESEARCH (2005)
Relationship of CD4+CD25+regulatory T cells to immune status in HIV-infected patients
S Tsunemi et al.
AIDS (2005)
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
JJ Mattapallil et al.
NATURE (2005)
Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self
S Sakaguchi
NATURE IMMUNOLOGY (2005)
Interleukin-15 increases effector memory CD8+ T cells and NK cells in simian immunodeficiency virus-infected macaques
YM Mueller et al.
JOURNAL OF VIROLOGY (2005)
Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: Analysis of immunophenotypic marker results of AACTG 5067
R D'Amico et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2005)
The roles of CD25+CD4+ regulatory T cells in operational tolerance after living donor liver transplantation
A Yoshizawa et al.
TRANSPLANTATION PROCEEDINGS (2005)
Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy
CC Johansson et al.
AIDS (2004)
HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells
K Oswald-Richter et al.
PLOS BIOLOGY (2004)
Combination antiretroviral therapy and the risk of myocardial infarction
N Friis-Moller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Persistent immune activation in HIV-1 infection is associated with progression to AIDS
MD Hazenberg et al.
AIDS (2003)
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America
JP Lalezari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia
A Lazzarin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopenia
G Carcelain et al.
AIDS (2003)
Differential impairment of lytic and cytokine functions in senescent human immunodeficiency virus type 1-specific cytotoxic T lymphocytes
M Dagarag et al.
JOURNAL OF VIROLOGY (2003)
Severe CD4(+) T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy
M Guadalupe et al.
JOURNAL OF VIROLOGY (2003)
Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors
JM Benito et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2002)
Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis
TW Schacker et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis
P Delobel et al.
JOURNAL OF NEUROCHEMISTRY (2002)
CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load
AE Sousa et al.
JOURNAL OF IMMUNOLOGY (2002)
Immunological and virological factors at baseline may predict response to structured therapy interruption in early stage chronic HIV-1 infection
F García et al.
AIDS (2002)
Low-dose prolonged intermittent interleukin-2 adjuvant therapy: Results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment
G Marchetti et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Thymic involvement in immune recovery during antiretroviral treatment of HIV infection in adults; comparison of CT and sonographic findings
L Kolte et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2002)
Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy
L Kolte et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone
LA Napolitano et al.
AIDS (2002)
Effects of exogenous interleukin-7 on human thymus function
Y Okamoto et al.
BLOOD (2002)
Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood
S Kimmig et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals
A Llano et al.
JOURNAL OF VIROLOGY (2001)
CD4+CD25high regulatory cells in human peripheral blood
C Baecher-Allan et al.
JOURNAL OF IMMUNOLOGY (2001)
Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen
C Piketty et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease
SR Broussard et al.
JOURNAL OF VIROLOGY (2001)
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
G Greub et al.
LANCET (2000)
Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo
KS Schluns et al.
NATURE IMMUNOLOGY (2000)
T cell depletion in HIV-I infection:: how CD4+ T cells go out of stock
MD Hazenberg et al.
NATURE IMMUNOLOGY (2000)
Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution
DC Douek et al.
LANCET (2000)
Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection
MD Hazenberg et al.
NATURE MEDICINE (2000)
Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy
KY Smith et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
